,
The National Agency for Food and Drug Administration and Control is informing healthcare providers that Medicines & Healthcare products
Regulatory Agency (MHRA) in conjunction with Dermaved is recalling Dermaved Sensitive Cream due to presence of clobetasol propionate (0.001% w/w).
Clobetasol propionate is a strong steroid and it is an active ingredient in Prescription Only Medicines used for the treatment skin conditions such as psoriasis and eczema. Creams containing steroids should be used sparingly and as directed by the prescriber.
Although the presence of clobetasol propionate in this product is low, patients are advised to stop using the cream immediately, particularly pregnant and breastfeeding women, babies and young children.
Possible Risk
There have been infrequent cases of skin reactions after stopping the use of creams containing steroids.
Product Detail
The details of the recalled lots are as follows;
Product Manufacturer: Dermaved
Product description: Dermaved Sensitive Cream (unlicensed medicine)
MDR Number: MDR 251-12/21
| Batch Number | Expiry Date | Pack Size | First Distributed |
| 002001 | February 2025 | 100ml | December 2020 |
NAFDAC implores importers, distributors, retailers, healthcare providers and consumers to exercise caution in the importation, distribution, sale and use of Dermaved Sensitive Cream.
Members of the public if in possession of the recalled lot of the product are implored to discontinue sale or use and handover stock to the nearest NAFDAC office.
NAFDAC encourages healthcare professionals, consumers and patients to report adverse events related to the use of this product to the nearest NAFDAC office, NAFDAC PRASCOR (20543 TOLLS FREE from all networks) or via pharmacovigilance@nafdac.gov.ng or via the NAFDAC ADR e-Reporting platform available at www.nafdac.gov.ng
NAFDAC……..Customer-focused, Agency-minded!!!
Signed Management
